- Stocks
- Healthcare
- NASDAQ: LMNX

Price (delayed)

$36.79

Market cap

$1.74B

P/E Ratio

73.58

Dividend/share

$0.39

EPS

$0.5

Enterprise value

$1.74B

The mission of Luminex is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. The Company offers a wide range of solutions applicable in diverse markets

Luminex's quick ratio has soared by 172% YoY and by 38% from the previous quarter

The net income has soared by 56% from the previous quarter

LMNX's P/E is 23% above its 5-year quarterly average of 59.6 but 14% below its last 4 quarters average of 85.7

Luminex's equity has decreased by 6% QoQ but it has increased by 6% YoY

LMNX's debt is up by 25% QoQ

What are the main financial stats of LMNX

Market
Valuations
Earnings

Shares outstanding

47.31M

Market cap

$1.74B

Enterprise value

$1.74B

Price to earnings (P/E)

73.58

Price to book (P/B)

3.52

Price to sales (P/S)

3.86

EV/EBIT

33.09

EV/EBITDA

20.84

EV/Sales

3.97

Revenue

$437.66M

EBIT

$52.55M

EBITDA

$83.44M

Free cash flow

$8.28M

Per share
Balance sheet
Liquidity

EPS

$0.5

Free cash flow per share

$0.18

Book value per share

$10.45

Revenue per share

$9.54

TBVPS

$13.62

Total assets

$819.03M

Total liabilities

$330.98M

Debt

$269.57M

Equity

$488.05M

Working capital

$424.22M

Debt to equity

0.55

Current ratio

8.37

Quick ratio

5.92

Net debt/EBITDA

-0.02

Margins
Efficiency
Dividend

EBITDA margin

19.1%

Gross margin

60.3%

Net margin

5.3%

Operating margin

12.4%

Return on assets

2.9%

Return on equity

4.6%

Return on invested capital

11.1%

Return on capital employed

6.9%

Return on sales

12%

Dividend yield

1.06%

DPS

$0.39

Payout ratio

78%

How has the Luminex stock price performed over time

Intraday

-0.27%

1 week

-0.16%

1 month

0.57%

1 year

27.3%

YTD

59.13%

QTD

15.33%

How have Luminex's revenue and profit performed over time

Revenue

$437.66M

Gross profit

$263.97M

Operating income

$54.26M

Net income

$23.13M

Gross margin

60.3%

Net margin

5.3%

The net income has soared by 56% from the previous quarter

LMNX's net margin is up by 47% QoQ

LMNX's gross profit is up by 41% YoY and by 7% from the previous quarter

LMNX's operating income is up by 28% since the previous quarter

What is Luminex's growth rate over time

What is Luminex stock price valuation

P/E

73.58

P/B

3.52

P/S

3.86

EV/EBIT

33.09

EV/EBITDA

20.84

EV/Sales

3.97

The company's EPS has surged by 52% QoQ

LMNX's P/E is 23% above its 5-year quarterly average of 59.6 but 14% below its last 4 quarters average of 85.7

LMNX's price to book (P/B) is 53% more than its 5-year quarterly average of 2.3 and 35% more than its last 4 quarters average of 2.6

Luminex's equity has decreased by 6% QoQ but it has increased by 6% YoY

Luminex's revenue has increased by 28% YoY and by 4.9% from the previous quarter

The P/S is 21% more than the 5-year quarterly average of 3.2 and 21% more than the last 4 quarters average of 3.2

How efficient is Luminex business performance

LMNX's return on equity has surged by 53% since the previous quarter

The return on assets has increased by 45% since the previous quarter

The company's return on sales rose by 24% QoQ

The ROIC has grown by 8% from the previous quarter

What is LMNX's dividend history

DPS

$0.39

Dividend yield

1.06%

Payout ratio

78%

Recent dividends

How did Luminex financials performed over time

LMNX's total assets is 147% higher than its total liabilities

Luminex's quick ratio has soared by 172% YoY and by 38% from the previous quarter

The company's current ratio has surged by 109% YoY and by 44% QoQ

LMNX's debt is 45% lower than its equity

The company's debt to equity rose by 31% QoQ

LMNX's debt is up by 25% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.